JAMA Infectious Diseases Theme Issue: Deadline April 15, 2014

Just in time for the holidays, Santa has left a gift for ID folks under the tree. I'm not talking about the recent action by FDA to ask the livestock industry to stop using antibiotics for growth promotion, nor am I talking about the FDA's proposed rule to "require manufacturers to provide more substantial data to demonstrate the safety and effectiveness of antibacterial soaps (that contain triclosan or triclocarban)."  While I'm very excited about those developments, I'm pretty sure Santa doesn't work at the FDA.

What I am attempting to highlight is JAMA's ID theme issue planned for October 2014. I offer a few select quotes from the call for papers written by Preeti Malani and Michael Berkwits:

"Ironically, while advances in public health have been driven historically by management of infections, the body of evidence that guides contemporary practice in infectious diseases remains relatively limited."

"Clinical trials rarely can fill a journal issue, and important clinical questions far exceed the number of trials that can be planned, so we invite authors to submit research with other designs and approaches."

"Studies that present new information relevant to optimizing treatment strategies and prevention efforts, and those that enhance the understanding of quality-of-life and economic consequences of infection are also of interest."

Let's hope this theme issue has some new science in the fields of infection prevention, antibacterial resistance and stewardship. Deadline April 15th!